Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 142865, 3 pages
http://dx.doi.org/10.1155/2013/142865
Case Report

Ibuprofen-Induced Hemolytic Anemia

Department of Internal Medicine, Saint Joseph Hospital, 2900 N. Lake Shore, Chicago, IL 60657, USA

Received 22 February 2013; Accepted 3 April 2013

Academic Editors: R. Herrmann, K. Kawauchi, Y. Shiozawa, and R. Tiu

Copyright © 2013 Aram Barbaryan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. D. Petz and G. Garratty, Immune Hemolytic Anemias, Churchill Livingstone, Philadelphia, Pa, USA, 2nd edition, 2004.
  2. G. Garratty, “Immune hemolytic anemia associated with drug therapy,” Blood Reviews, vol. 24, no. 4-5, pp. 143–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. T. Johnson, J. T. Fueger, and J. L. Gottschall, “One center's experience: The serology and drugs associated with drug-induced immune hemolytic anemia—a new paradigm,” Transfusion, vol. 47, no. 4, pp. 697–702, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. W. Kaufman, J. P. Kelly, C. B. Johannes et al., “Acute thrombocytopenic purpura in relation to the use of drugs,” Blood, vol. 82, no. 9, pp. 2714–2718, 1993. View at Google Scholar · View at Scopus
  5. E. Andrés and F. Maloisel, “Idiosyncratic drug-induced agranulocytosis or acute neutropenia,” Current Opinion in Hematology, vol. 15, pp. 15–21, 2008. View at Google Scholar
  6. A. Pierce and T. Nester, “Pathology consultation on drug-induced hemolytic anemia,” American Journal of Clinical Pathology, vol. 136, no. 1, pp. 7–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. D. Zantek, S. A. Koepsell, D. R. Tharp Jr, and C. S. Cohn, “The direct antiglobulin test: a critical step in the evaluation of hemolysis,” American Journal of Hematology, vol. 87, no. 7, pp. 707–709, 2012. View at Publisher · View at Google Scholar
  8. H. Gonzalez, V. Leblond, N. Azar et al., “Severe autoimmune hemolytic anemia in eight patients treated with fludarabine,” Hematology and Cell Therapy, vol. 40, no. 3, pp. 113–118, 1998. View at Google Scholar · View at Scopus
  9. H. Myint, J. A. Copplestone, J. Orchard et al., “Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia,” British Journal of Haematology, vol. 91, no. 2, pp. 341–344, 1995. View at Google Scholar · View at Scopus
  10. P. P. Young, A. Uzieblo, E. Trulock, D. M. Lublin, and L. T. Goodnough, “Autoantibody formation after alloimmunization: are blood tranfusions a risk factor for autoimmune hemolytic anemia?” Transfusion, vol. 44, no. 1, pp. 67–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. P. C. Hoffman, “Immune hemolytic anemia—selected topics,” Hematology, pp. 80–86, 2009. View at Google Scholar · View at Scopus
  12. D. M. Keeling and D. A. Isenberg, “Haematological manifestations of systemic lupus erythematosus,” Blood Reviews, vol. 7, no. 4, pp. 199–207, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Giannadaki, S. Potamianos, M. Roussomoustakaki, D. Kyriakou, N. Fragkiadakis, and O. N. Mahousos, “Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitis,” American Journal of Gastroenterology, vol. 92, no. 10, pp. 1872–1874, 1997. View at Google Scholar · View at Scopus